Left heart morphology and function in primary aldosteronism

High Blood Pressure and Cardiovascular Prevention

Volumn 19, Issue 1, 2012, Pages 11-17

  Milan, Alberto ^a   Magnino, Corrado ^a   Fabbri, Ambra ^a   Chiarlo, Michela ^a   Bruno, Giulia ^a   Losano, Isabel ^a   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Aldosterone; Echocardiography; Hypertension; Hypertrophy; Left ventricular mass; Primary aldosteronism

Indexed keywords

CARDIAC IMAGING; DIASTOLE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HUMAN; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN WEIGHT; PHENOTYPE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SYSTOLE;

EID: 84861951589     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11593690-000000000-00000     Document Type: Review

References (44)

1. Omura M, Saito J, Yamaguchi K, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193-202 (Pubitemid 38489081)
2. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-50 (Pubitemid 38368386)
3. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-300 (Pubitemid 44873058)
4. Douma S, Petidis K, Doumas M, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-6 (Pubitemid 351778191)
5. Ito Y, Takeda R, Karashima S, et al. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res 2011; 34: 98-102
6. Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-8 (Pubitemid 40523144)
7. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168: 80-5
8. Campbell SE, Diaz-Arias AA, Weber KT. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1992; 1: 149-56
9. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993; 25: 563-75 (Pubitemid 23208145)
10. Rossi GP, Di Bello V, Ganzaroli C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002; 40: 23-7 (Pubitemid 34755974)
11. Kozàkovà M, Buralli S, Palombo C, et al. Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 2003; 41: 230-6 (Pubitemid 36204894)
12. Galetta F, Bernini G, Franzoni F, et al. Cardiac remodeling in patients with primary aldosteronism. J Endocrinol Invest 2009; 32: 739-45
13. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-81
14. Suzuki T, Abe H, Nagata S, et al. Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism. Am J Cardiol 1988; 62: 1224-7
15. Janota T, Hradec J, Krá l J. Heart in adrenal diseases. Cor Vasa 1992; 34: 115-22 (Pubitemid 23144513)
16. Denolle T, ChatellierG, Julien J, et al. Left ventricularmass and geometry before and after etiologic treatment in renovascular hypertension, aldosteroneproducing adenoma, and pheochromocytoma. Am J Hypertens 1993; 6: 907-13 (Pubitemid 23363177)
17. Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039-45 (Pubitemid 26140658)
18. Rossi GP, Sacchetto A, Pavan E, et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997; 95: 1471-8 (Pubitemid 27142805)
19. Tanabe A, Naruse M, Naruse K, et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 1997; 20: 85-90
20. Shigematsu Y, Hamada M, Okayama H, et al. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997; 29: 723-7 (Pubitemid 27097976)
21. Rossi GP, Sacchetto A, Pavan E, et al. Left ventricular systolic function in primary aldosteronism and hypertension. J Hypertens 1998; 16: 2075-7 (Pubitemid 29002390)
22. Goldkorn R, Yurenev A, Blumenfeld J, et al. Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension. Am J Hypertens 2002; 15: 340-5 (Pubitemid 34408974)
23. Matsumura K, Fujii K, Oniki H, et al. Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 2006; 19: 13-8 (Pubitemid 43217027)
24. Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50: 911-8 (Pubitemid 350287534)
25. Muiesan ML, Salvetti M, Paini A, et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension 2008; 52: 529-34
26. Iacobellis G, Petramala L, Cotesta D, et al.Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab 2010; 95: 2391-8
27. Lin YH, Wang SM, Wu VC, et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. Eur J Clin Invest 2011; 41: 743-50
28. Pimenta E, Gordon RD, Ahmed AH, et al. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. J Clin Endocrinol Metab 2011; 96: 2813-20
29. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108 (Pubitemid 43257193)
30. Swamy RS, Lang RM. Echocardiographic quantification of left ventricular mass: prognostic implications. Curr Cardiol Rep 2010; 12: 277-82
31. de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444-51 (Pubitemid 24158016)
32. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-33
33. Leung DY, Boyd A, Ng AA, et al. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. Am Heart J 2008; 156: 1056-64
34. Gaddam K, Corros C, Pimenta E, et al. Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study. Hypertension 2010; 55: 1137-42
35. Choi EY, Ha JW, Yoon SJ, et al. Increased plasma aldosterone-to-renin ratio is associated with impaired left ventricular longitudinal functional reserve in patients with uncomplicated hypertension. J Am Soc Echocardiogr 2008; 21: 251-6
36. Tarazi RC, Ibrahim MM, Bravo EL, et al. Hemodynamic characteristics of primary aldosteronism. N Engl J Med 1973; 289: 1330-5
37. Tunny TJ, Gordon RD, Klemm SA, et al. Reduced renal extraction of atrial natriuretic peptide in primary aldosteronism. Hypertension 1995; 26: 624-7
38. Kato J, Etoh T, Kitamura K, et al. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am J Hypertens 2005; 18: 354-7 (Pubitemid 40409916)
39. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168: 1159-64 (Pubitemid 351831398)
40. Pimenta E, Gaddam KK, Pratt-Ubunama MN, et al. Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension 2008; 51: 339-44 (Pubitemid 351159948)
41. Marwick TH. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart 2003; 89 Suppl. 3: iii2-8 (Pubitemid 37311139)
42. Abe M, Hamada M, Matsuoka H, et al. Myocardial scintigraphic characteristics in patients with primary aldosteronism. Hypertension 1994; 23: I164-7 (Pubitemid 24020442)
43. de Simone G, Izzo R, Chinali M, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010; 56: 99-104
44. Reil JC, Hohl M, Selejan S, et al. Aldosterone promotes atrial fibrillation. Eur Heart J. In press Reil JC, Hohl M, Selejan S, et al. Aldosterone promotes atrial fibrillation. Eur Heart J. In press